Press Releases

MOBILE, Ala.--(BUSINESS WIRE)--

International Shipholding Corporation ("the Company") (NYSE: ISH) announced today that it expects its net income for the Quarter ended 09/30/08 to be approximately $11.0 to $11.5 million or $1.51 to $1.59 per share on a fully diluted basis. The Company's results for the third quarter were primarily driven by an increase in the carriage of supplemental cargoes on its U.S. Flag Pure Car Carriers which increased over second quarter liftings and by the continued improvement in the results of the Rail Ferry service as it moves closer to maximizing its carrying capacity. The Company had no asset sales in the third quarter, and, additionally, based on the Third Quarter's results, the Company had approximately $50 million of cash and cash equivalents at 09/30/08.

While the recent down turn in the dry bulk market has impacted shipping companies with vessels in the spot market, the Company's long standing strategy of having its fleet employed under medium to long term charters with charterers of high credit rating allows the Company's time charter segment to continue to provide consistent and predictable returns. These charters have no exposure to fluctuating fuel prices. Our only segment exposed to fuel price levels, the Rail Ferry service, has existing surcharge agreements in place that are designed to essentially eliminate material cost increases.

The Company plans to formally release its earnings on October 30th after its Third Quarter Board meeting.

In addition to historical information, this release includes certain forward-looking statements and estimates that are based on current expectations only, and are subject to a number of risks, uncertainties and assumptions, many of which are beyond the control of the Company. Actual events and results may differ materially from those anticipated or estimated if one or more of these risks or uncertainties materialize, or if underlying assumptions prove incorrect. You should be aware that the Company has not yet completed its process of gathering the information necessary to compile, complete and release financial statements as of and for the period ended September 30, 2008 in accordance with generally accepted accounting principles. Other factors that could affect actual results include but are not limited to: changes in the financial position of the Company's customers or in the Company's charters or other contracts with such customers; changes in cargo, charterhire and vessel utilization rates; unplanned maintenance on our vessels; continued volatility and further deterioration of the credit and capital markets; other risks referenced from time to time in the Company's filings with the Securities and Exchange Commission (the "SEC"); and the effects of more general factors such as changes in interest rates, in tax rates, in accounting policies or practices, in operating or administrative costs, in general market, labor or economic conditions, or in legislation, regulation or public policy. These and other uncertainties related to the Company's business and plans are described in greater detail in the Company's Annual Report on Form 10-K for the year ended December 31, 2007, as updated and supplemented by the Company's subsequent SEC reports. You are further cautioned not to place undue reliance on these forward-looking statements, which speak only as of October 13, 2008. The Company undertakes no obligation to update any of its forward-looking statements for any reason.

International Shipholding Corporation (NYSE: ISH), through its subsidiaries, operates a diversified fleet of U.S. and foreign flag vessels that provide international and domestic maritime transportation services to commercial and governmental customers primarily under medium to long-term charters and contracts. www.intship.com

Source: International Shipholding Corporation

SINGAPORE--(BUSINESS WIRE)--

A-Bio Pharma Pte Ltd. today announced that Dr. Steven S. Lee, Ph.D., has joined the company as its Chief Executive Officer. Steve joins A-Bio from pharmaceutical giant Bristol Myers Squibb Company (BMS), where he held the position of Vice President and General Manager of the Syracuse, New York Manufacturing and Process Development Complex overseeing over 800 employees and a wide range of biological drugs and development candidates including antibody therapeutics.

"I am very pleased that Steve has taken the helm at A-Bio," said Chu Swee Yeok, CEO of Bio*One Capital. "Steve has many years of biologics manufacturing experience. He will bring his invaluable seasoned perspective to A-Bio and lead the company into the next important phase of expansion and exciting growth."

Bio*One Capital, the main investor in A-Bio, has been instrumental in developing A-Bio as the pioneering biologics player in Singapore. After acquiring Biopharmaceutical Manufacturing Technology Centre (BMTC), A-Bio has grown into a strong provider of a full range of process development and GMP manufacturing services. Its customers include large global pharmaceutical companies as well as biotechnology companies.

"I am delighted to join A-Bio with its experienced team of engineers, scientists and GMP trained employees," said Dr. Lee. "As the global development and manufacturing hub for biologics, Singapore is in a unique position today; it is located at the center of the talent pools and markets of Australia, China and India at a time when the biotech industry is expanding worldwide. I envision enormous potential for growth for A-Bio as global biologics businesses move to new markets in Asia. A-Bio in Singapore is well positioned to capitalize on such growing opportunities."

Prior to joining BMS in 2002, Dr. Lee was Director of Fermentation and Cell Culture Development at Merck's West Point, Pennsylvania vaccine facility, where he held several positions of increasing responsibility at Merck Research Laboratories and Merck Manufacturing Division since joining in 1990. Dr. Lee received his doctorate in Biochemical Engineering from the Massachusetts Institute of Technology and a Master's in Chemical engineering from the University of Michigan, Ann Arbor.

About A-Bio

A-Bio is one of Asia's leading biologics contract manufacturers. It provides a full range of GMP manufacturing capabilities for biological protein manufacturing scale-up, cGMP production and regulatory compliance. Within four years of operation, A-Bio has established a strong track record with customers such as GlaxoSmithKline Biologicals, Novo Nordisk, Artisan Pharma and others. For more on A-Bio: www.a-bio.com.

About Bio*One Capital

Bio*One Capital, the major shareholder of A-Bio, is a leading, dedicated biomedical sciences investment management company in Asia with a worldwide presence. Its investments are focused on promising global biomedical companies where Bio*One Capital can play a value adding role in bridging and supporting companies' growth strategies in Asia. Through its extensive networks with global companies and venture capital corporations, Bio*One Capital proactively facilitates partnering and collaborative opportunities to help its portfolio companies grow into sustainable and successful ventures. For more on Bio*One Capital: www.bio1capital.com.

Source: A-Bio Pharma Pte Ltd.

ST. LOUIS, Oct. 13 /PRNewswire-FirstCall/ -- CleanTech Biofuels, Inc. (OTC Bulletin Board: CLTH) announces that it has closed the merger of Biomass North America Licensing, Inc. into its wholly-owned subsidiary.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080106/CLSU020LOGO)

CleanTech plans to move quickly to implement its newly acquired technology at a commercial waste transfer station in Chicago, Illinois to produce cellulosic biomass from municipal solid waste. In cooperation with the owner of the site, the permitting and approval process for construction of the plant is underway.

The cellulosic biomass to be produced at the facility can be used for a variety of purposes, including solid fuel for the production of electricity in existing coal-fired power plants. CleanTech has been approached by several utilities who desire to purchase the biomass from the proposed Chicago plant for use in existing power plants.

Mayor Richard M. Daley recently announced a plan to dramatically slash emissions of heat-trapping gases, part of an effort to fight global warming and make Chicago one of the greenest cities in the nation.

CleanTech's municipal solid waste to energy platform is a significant step towards fulfilling Mayor Daley's vision.

About CleanTech Biofuels, Inc.:

CleanTech Biofuels, Inc. is a development stage company with technology that the company believes is capable of converting municipal solid waste into ethanol and other energy products. By using the existing infrastructure for municipal solid waste collection and disposal to collect biomass at low or possibly negative feedstock cost, the Company expects to achieve profitability quickly relative to other energy producers who must develop their infrastructure to collect and transport more expensive feedstocks such as sugar cane, corn or even switchgrass, wood waste, or corn stover.

Safe Harbor:

This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The risks and uncertainties that may affect the operations, performance development, and results of the Company's business include but are not limited to fluctuations in financial results, availability and customer acceptance of our products and services, the impact of competitive products, services and pricing, general market trends and conditions, and other risks detailed in the Company's SEC reports.

SOURCE CleanTech Biofuels, Inc.

NEW YORK--(BUSINESS WIRE)--

Dr. Kenneth H. Cooper, founder and chairman of Cooper Aerobics Center, Dallas and McKinney, TX, will receive the Lifetime Achievement Award from Club Industry's Fitness Business Pro magazine at the Club Industry 2008 Conference and Trade Show in Chicago. The magazine will present Dr. Cooper with the award at 11:30 a.m. on Thursday, Oct. 16, prior to Dr. Cooper giving the keynote address at the event.

Dr. Cooper coined the term "aerobics" in 1968, shortly afterwards, publishing a book titled "Aerobics" that became the first of 19 books he's published. In 1970, he opened the Cooper Aerobics Center in Dallas, a facility that now encompasses 10 businesses, including a preventive medicine clinic, fitness center and spa, and a nonprofit research institute. He opened a second location in McKinney, TX, in 2006. Dr. Cooper has spoken internationally about the importance of exercise. Most recently, he has become involved in efforts to test the fitness of school children in an effort to decrease the problem of childhood obesity.

"We're very excited to present this award to Dr. Cooper this year," said Pamela Kufahl, editor of Club Industry's Fitness Business Pro magazine, based in Overland Park, KS. "He's made a significant difference in the fitness industry and in the health of Americans through his research on exercise and wellness, both creating and popularizing the term aerobics, his books, his former radio show and his international speaking engagements. He's an outstanding representative of the fitness industry, and he's done more to wake people up to the importance of exercise than almost anyone else in the business."

This is the sixth year that Club Industry's Fitness Business Pro magazine has given out a Lifetime Achievement Award. Previous winners were Joe Weider, founder of Weider Publications; Joe Gold, founder of Gold's Gym and World Gym; Judi Sheppard Missett, founder of Jazzercise; Rick Caro, president of Management Vision; and Alan Schwartz, co-founder of TCA Holdings. Profiles of these individuals and of Dr. Cooper can be found on the magazine's Web site: http://fitnessbusinesspro.com/awardsrankings/.

Club Industry's Fitness Business Pro magazine, now celebrating its 25th anniversary, is a monthly publication featuring news and trends focusing on issues of importance to owners and managers of fitness facilities. For more information about the magazine, go to www.fitnessbusinesspro.com.

Club Industry 2008 addresses the business needs of the entire professional fitness industry, for both for-profit and non-profit operations. It attracts multipurpose clubs and gyms, YM/YWCAs and JCCs, hospitals/ medical wellness centers, colleges, universities, schools, corporate fitness centers, municipal park and recreation/community centers, hotels/resorts/spas and government/military fitness operations, as well as personal trainers. It features an exhibit hall with more than 200 leading suppliers of cardiovascular and strength equipment, as well as all other products and services for fitness facilities. The exhibits run from Thursday, Oct. 16 through Saturday, Oct. 18.

Also presented will be a wide-ranging conference program with more than 150 seminars on topics of interest to fitness professionals, including inclusive fitness, nutrition and weight loss, corporate fitness, wellness/medical integration, personal training and more. Conference sessions begin on Wednesday, Oct. 15. For more information, visit www.clubindustryshow.com. Both the show and magazine are owned by Penton Media, Inc.

To obtain press credentials for the show, please contact Herb Greenebaum, Marketing Manager, at (203) 358-3710 or (203) 675-6978 or email herbert.greenebaum@penton.com.

Penton Media, Inc. is the largest independent business-to-business media company in the U.S., serving more than six million business professionals every month. The company's market-leading brands are focused on 30 industries and include 113 trade magazines, 145 Web sites, 150 industry trade shows and conferences, and more than 500 information data products. Headquartered in New York City, the privately held company is owned by MidOcean Partners and U.S. Equity Partners II, an investment fund sponsored by Wasserstein & Co., LP, and its co-investors. For additional information on the company and its businesses, visit www.penton.com.

Source: Penton Media, Inc.

FORT LAUDERDALE, FL -- (MARKET WIRE) -- 10/13/08 -- Colodny, Fass, Talenfeld, Karlinsky & Abate Shareholder Fred Karlinsky and Partner Richard Fidei recently handled the Florida Office of Insurance Regulation (FLOIR) regulatory work to complete the acquisition of AmCOMP Incorporated by EMPLOYERS Holdings, Inc. (EMPLOYERS). EMPLOYERS entered into an amendment to its merger agreement with AmCOMP, allowing for the acquisition. Under the agreement, holders of AmCOMP's approximately 15 million common shares outstanding will receive $12.15 per share in cash, for a total of $182.3 million.

In order to obtain regulatory approval from the Office of Insurance Regulation (OIR), the team's work included facilitating the application process, working and negotiating with regulators, and answering questions for their client -- EMPLOYERS. The firm also advised EMPLOYERS on AmCOMP's resolution of excess profits of $8.4 million held by the company. The merger was approved by the OIR on September 2, 2008.

The transaction, which is subject to approval of AmCOMP's stockholders and other customary closing conditions, is expected to be completed in late October. EMPLOYERS plans to finance the purchase price through a combination of cash and debt.

EMPLOYERS is a holding company with subsidiaries that specialize in workers' compensation insurance and other services for small businesses working in low-to-medium hazard industries. The company's subsidiaries, Employers Insurance Company of Nevada and Employers Compensation Insurance Company, are rated A- (Excellent) by the A.M. Best Company.

AmCOMP also specializes in workers' compensation insurance for small- to mid-sized employers. Its subsidiaries, AmCOMP Preferred Insurance Company and AmCOMP Assurance Corporation, focus exclusively on workers' compensation insurance. AmCOMP is a 25-year-old company and has offices in North Palm Beach and Maitland.

Colodny, Fass, Talenfeld, Karlinsky & Abate, P.A. is a full-service law firm specializing in government relations, commercial litigation and administrative law, with offices in Fort Lauderdale and Tallahassee. The Firm's litigation practice group also handles civil rights, employment discrimination and child advocacy matters on both the trial and appellate levels. For more information, visit www.ctflaw.com or call (954) 492-4010 or (850) 577-0398 in Tallahassee.

CONTACT:
Don Silver
Michelle Friedman
Boardroom Communications
http://www.boardroompr.com
954-370-8999
Email Contact
for Colodny, Fass, Talenfeld, Karlinsky & Abate, P.A.